Date and time
Start: Thursday 15 April 2021, 02:00 PM
End: Thursday 15 April 2021, 03:00 PM
Thursday 15 April
Start: Thursday 15 April 2021, 02:00 PM
End: Thursday 15 April 2021, 03:00 PM
Subject-matter eligibility for life sciences inventions is an ongoing concern among applicants seeking patent protection at the USPTO. Claims that are granted in line with the USPTO guidelines for subject-matter eligibility can still fall for this same ground at the Federal Circuit. Happily, subject-matter eligibility is less controversial at the EPO. However, problems can arise when applicants try to file an EPO drafted application at the USPTO, and vice versa. In this webinar, we will look at recent updates in the case law, current USPTO guidance on Section 101, and strategies for balancing the (sometimes conflicting) requirements of the EPO and USPTO.
Fellows, Students
Victoria is an associate in Finnegan’s London office, with experience in all areas of patent portfolio management from drafting and filing applications to prosecution strategy and beyond to EPO opposition and appeal procedures. Victoria’s experience spans a broad range of chemical technologies and key jurisdictions including China, Japan, and Korea.
Amanda Murphy, Ph.D., brings over 17 years of experience to her life sciences intellectual property practice. As a U.S. patent attorney practicing in London, Amanda is ideally situated to counsel clients on their global patent strategies. Her practice includes patent application preparation and prosecution, pre-litigation portfolio and due diligence analyses, and contentious PTAB proceedings.
The event has been added to your basket:
Sign in to your account to register for the event
If you are not yet registered or a member of CIPA, please register here